is fda banning semaglutide Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide FDA approves obesity drug that

What does the PlexusDx Precision Peptide Genetic Test reveal about GLP-1 response

Although it tends to be that most of the headlines surrounding Ozempic, Wegovy, and the other weight-loss 'skinny jabs' are focused on the negatives, one man claims to have experienced an unexpected side effect...in his pants

People enrolled in a clinical trial should contact the study team according to the trial instructions

Semaglutide belongs to a class of medications known as GLP-1 receptor agonists (Glucagon-Like Peptide-1)

Traumatic brain injuries: pathophysiology and potential therapeutic targets

Traditional therapies, such as GLP-1 receptor agonists (e.g., semaglutide), have shown efficacy but often fall short in achieving comprehensive metabolic control